mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Carboplatin |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
Crizotinib |
CCLE |
pan-cancer |
AAC |
-0.019 |
0.7 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |